Angiotensin converting enzyme and methylenetetrahydrofolate reductase gene variations in fibromyalgia syndrome

Gene

Volumn 564, Issue 2, 2015, Pages 188-192

  Inanir, Ahmet ^a   Yigit, Serbulent ^a   Tekcan, Akin ^b   Pinarli, Ferda Alpaslan ^c   Inanir, Sema ^a   Karakus, Nevin ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b AHI EVRAN UNIVERSITY   (Turkey)

^c SB Ankara Diskapi Training and Research Hospital   (Turkey)

Author keywords

ACE I D; Fibromyalgia syndrome; MTHFR C677T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DIPEPTIDYL CARBOXYPEPTIDASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FIBROMYALGIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROMYALGIA; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 84928210211     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.03.051     Document Type: Article

References (39)

1. Ablin J., Neumann L., Buskila D. Pathogenesis of fibromyalgia. Joint Bone Spine 2008, 75:273-279.
2. Alayli G., Durmus D., Ozkaya O., Sen H.E., Genc G., Kuru O. Frequency of juvenile ibromyalgia syndrome in children with familial Mediterranean fever: effects on depression and quality of life. Clin. Exp. Rheumatol. 2011, 29:127-132.
3. Arnold L.M., Fan J., Russell I.J., Yunus M.B., Khan M.A., Kushner I., Olson J.M., Iyengar S.K. The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum. 2013, 65(4):1122-1128. (Apr).
4. Baudin B., Berard M., Carrier J.L., Legrand Y., Drouet L. Vascular origin determines angiotensin I-converting expression in endothelial cells. Endothelium 1997, 5:73-84.
5. Bondy B. Common genetic risk factors for psychiatric and somatic disorders. Dialogues Clin. Neurosci. 2003, 5(2):129-138. (Jun).
6. Bondy B. Common genetic risk factors for psychiatric and somatic disorders. Dialogues Clin. Neurosci. 2003, 5:129-138.
7. Bondy B., Baghi T.C., Zill P. Combined action of the ACE D- and G protein B3 T-allele in major depression: a possible link to cardiovascular disease?. Mol. Psychiatry 2002, 7:1120-1126.
8. Bourcier T., Acosta M.C., Borderie V., Borrás F., Gallar J., Bury T., et al. Decreased corneal sensitivity in patients with dry eye. Invest. Ophthalmol. Vis. Sci. 2005, 46(7):2341-2345.
9. Brustolin S., Giugliani R., Félix T.M. Genetics of homocysteine metabolism and associated disorders. Braz. J. Med. Biol. Res. 2010, 43:1-7.
10. Butler R., Morris A.D., Burchell B., Struthers A.D. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999, 33:1164-1168.
11. Cardoso R., Gonçalo M., Tellechea O., Maia R., Borges C., Silva J.A., et al. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome. Int. J. Dermatol. 2007, 46:431-434.
12. Docampo E., Escaramís G., Gratacòs M., Villatoro S., Puig A., Kogevinas M., Collado A., Carbonell J., Rivera J., Vidal J., Alegre J., Estivill X., Rabionet R. Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system. Pain 2014, 155(6):1102-1109. (Jun).
13. Friso S., Girelli D., Trabetti E., Olivieri O., Guarini P., Pignatti P.F., et al. The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 2005, 14:938-943.
14. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10:111-113.
15. Gallar J., Morales C., Freire V., Acosta M.C., Belmonte C., Duran J.A. Decreased corneal sensitivity and tear production in fibromyalgia. Invest. Ophthalmol. Vis. Sci. 2009, 50(9):4129-4134.
16. Grodman I., Buskila D., Arnson Y., Altaman A., Amital D., Amital H. Understanding fibromyalgia and its resultant disability. IMAJ 2011, 13:769-772.
17. Gunduz H., Georges J.L., Fleishman S. Quinapril and depression. Am. J. Psychiatry 1999, 156:1114-1115.
18. Hayden M.R., Tyagi S.C. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr. J. 2004, 3:4.
19. Husemoen L.L., Toft U., Fenger M., Jørgensen T., Johansen N., Linneberg A. The association between atopy and factors influencing folate metabolism: is low folate status causally related to the development of atopy?. Int. J. Epidemiol. 2006, 35:954-961.
20. Inanir A., Yigit S., Tural S., Demir O.S., Akkanet S., Habiboğlu A. Significant association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and ankylosing spondylitis. Mol. Vis. 2012, 18:2107-2113.
21. Jenkins T.A., Mendelsohn-Frederick A.O., Chai S.Y. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J. Neurochem. 1997, 68:1304-1311.
22. Jeunemaitre X. Genetics of the human renin angiotensin system. J. Mol. Med. (Berl.) 2008, 86:637-641.
23. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998, 281:1640-1645.
24. Matsuda J.B., Barbosa F.R., Morel L.J., França Sde C., Zingaretti S.M., da Silva L.M., et al. Serotonin receptor (5-HT 2A) and catechol O methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia?. Bras. J. Rheumatol. 2010, 50:141-149.
25. Neumann L., Buskila D. Epidemiology of fibromyalgia. Curr. Pain Headache Rep. 2003, 7(5):362-368.
26. Ortega E., García J.J., Bote M.E., Martín-Cordero L., Escalante Y., Saavedra J.M., et al. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. Exerc. Immunol. Rev. 2009, 15:42-65.
27. Ozkul Y., Evereklioglu C., Borlu M., Taheri S., Calis M., Dündar M., et al. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br. J. Ophthalmol. 2005, 89:1634-1637.
28. Prasad A., Narayanan S., Waclawiw M.A., Epstein N., Quyyumi A.A. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity. J. Am. Coll. Cardiol. 2000, 36:1579-1586.
29. Price E.J., Venables P.J.W. Dry eyes and mouth syndrome: a subgroup of patients with sicca symptoms. Rheumatology 2002, 41:416-422.
30. Salemi S., Rethage J., Wollina U., Michel B.A., Gay R.E., Gay S., et al. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J. Rheumatol. 2003, 30:146-150.
31. Schmechel D.E., Edwards C.L. Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent. Neurotoxicology 2012, 33(6):1454-1472.
32. Smith S.B., Maixner D.W., Fillingim R.B., Slade G., Gracely R.H., Ambrose K., Zaykin D.V., Hyde C., John S., Tan K., Maixner W., Diatchenko L. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum. 2012, 64(2):584-593. (Feb).
33. Su S.Y., Chen J.J., Lai C.C., Chen C.M., Tsai F.J. The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin. Rheumatol. 2007, 26(1):12-16.
34. Topbas M., Cakirbay H., Gulec H., Akgol E., Ak I., Can G. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand. J. Rheumatol. 2005, 34:140-144.
35. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., Weisman M.H. Cytokines play an etiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 2001, 40:743-749.
36. Wang H., Moser M., Schiltenwolf M., Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia-a prospective longitudinal study over 6months. J. Rheumatol. 2008, 35:1366-1370.
37. Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995, 38:19-28.
38. Wotherspoon F., Laight D.W., Turner C., Meeking D.R., Allard S.E., Munday L.J., et al. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria. Int. J. Clin. Pract. 2008, 62:569-574.
39. Yigit S., Inanir A., Tekcan A., Inanir S., Tural S., Ates O. Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population. Gene 2013, 527(1):62-64.